Canada’s innovation paradox
Canada ranks 9th in research intensity but 26th in commercialization efficiency. The result: strong universities, weak scale-ups.
| Country | Business R&D (% GDP) | Unicorns (2024) | Source |
|---|---|---|---|
| United States | 2.1 % | 650 | CB Insights |
| Germany | 2.0 % | 85 | OECD |
| South Korea | 3.5 % | 30 | OECD |
| Israel | 4.9 % | 33 | IVC |
| Canada | 0.9 % | 23 | NRC 2025 |
Key lessons
- Innovation thrives where public funding transitions quickly to private capital.
- Procurement, not grants, drives scale.
- Corporate demand for domestic tech determines ecosystem maturity.
What leaders can do
- Pilot Canadian innovations within supply chains and operations.
- Fund later-stage commercialization. Partner with pension and venture capital funds.
- Measure innovation outcomes. Track patent-to-revenue ratios.
- Engage universities in co-development. Convert research into business models.
Arcus Insight: Innovation isn’t invention — it’s adoption. Without demand, Canada’s research output will remain potential, not performance.